NOVT Novanta Inc
405
$158.13
$3.71
(2.29%)
| Watchers | 405 |
| 52-Wk Low | $111.20 |
| 52-Wk High | $187.61 |
| Market Cap | $5.8B |
| Volume | 113,595.00 |
| 52-Wk High | $187.61 |
| 52-Wk Low | $111.20 |
Novanta Announces Financial Results for the First Quarter 2024Business Wire • 1 day ago
Novanta Inc. (Nasdaq: NOVT) (Novanta or the Company), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter...
Share to Feed
Novanta Inc. (Nasdaq: NOVT) (the 'Company'), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is...
Novanta Inc. (Nasdaq: NOVT) (the 'Company'), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive...
Novanta Inc. (Nasdaq: NOVT) (the Company), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2024 results on Tuesday, May 7...
Novanta's (NASDAQ:NOVT) stock up by 4.4% over the past month. Given its impressive performance, we decided to study the...
This indicator may be signaling NOVT's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Revolve Wealth Partners LLC acquired a new position in shares of Novanta Inc. (NASDAQ:NOVT Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired...
This indicator may be signaling NOVT's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
This is a signal that NOVT's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Novanta Inc. (NASDAQ:NOVT Free Report) Equities researchers at William Blair upped their FY2024 earnings per share estimates for shares of Novanta in a research report issued to...